Narcotics Bureau Introduces Online Submission Of Applications For Export & Import Of Narcotic Drugs

Mumbai : In a bid to facilitate ease of doing business in the wake of Covid-19 pandemic, the Central Bureau of Narcotics under Union finance ministry has asked exporters and importers of narcotic drugs, psychotropic substances and controlled substances to submit online application for export authorization, import certificate, no objection certificates (NOCs) for export and import of these products.

“Based on the spirit of government of India’s initiative regarding ease of doing business, regular changes in business, social, health related activities due to Covid-19 epidemic, considering the changing scenario of business and in order to facilitate the trade it has been decided that henceforth the exporter/importer of narcotic drugs, psychotropic substances, controlled substances can submit their applications online,” stated a notice issued by narcotics commissioner on January 13, 2022.

The exporters and importers need to send scanned copy of duly filled in application form along with copies of all the requisite documents including the import certificate duly self-attested by the authorized signatory of the company through email.

The application will be submitted only from the official email id of the firm along with challan of fee of Rs. 1,000.

Before submitting an application through email for export of narcotic drugs, psychotropic substances, controlled substances, the company should ensure to send the original import certificate, issued by the government of the importing country, by post/courier of sending original import certificate may be scanned and attached in mail. However, in such cases the export authorization will be issued only on receipt of original import certificate, according to Rule 58(2)(b) of NDPS Rules, 1985.

The exporter/importer should ensure to submit a single application for the intended export/import of narcotic drugs, psychotropic substances, and controlled substances. They should also ensure to send their application on the respective email id as given above. In case of submission of multiple applications and other than specific email, all the applications will not be considered.

The Central Bureau of Narcotics will issue the export authorization, import certificate, NOC after following the due procedure and the said export authorization, import certificate, NOC will be sent through a speed post to the company. The exporter/importer should submit one pdf file for one application. Multiple applications in a single pdf file shall not be entertained.

  • Related Posts

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise